As of Friday, November 07, Molecular Partners AG’s MOLN share price has dipped by 15.17%, which has investors questioning if ...
1don MSN
Mativ expects Q4 adjusted EBITDA to rise at least 10% year-over-year as portfolio review accelerates
Discover key Mativ Holdings Q3 2025 results: record EBITDA, cash flow gains, positive outlook, and strategic moves.
Q3 2025 Earnings Call November 6, 2025 8:30 AM ESTCompany ParticipantsChris Kuepper - Head of Investor RelationsShruti Singhal ...
2don MSN
Veracyte raises 2025 revenue outlook to $510M while accelerating double-digit growth investments
Q3 2025 Management View Marc Stapley, CEO, highlighted "another outstanding quarter" with core testing business revenue up 18% year-over-year after adjusting for Envisia, supported by 26% volume ...
It’s not just on Britain’s trains that I no longer feel safe - COMMENT: On the same evening as the Huntingdon train knife ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback